Evidence map›Paper›PMID 41189839›Full record

ArticleCureus2025

Dermatofibrosarcoma Protuberans: A Rare Anatomical Location of Dermal Sarcoma.

Chrysovalanti Oikonomidi, Eirini Lagogianni, Dimitrios Filippou, Dimosthenis Chrysikos

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chrysovalanti OikonomidiDepartment of Dermatology, University of Athens, Athens, GRC.
Eirini LagogianniDepartment of Dermatology, University of Athens, Athens, GRC.
Dimitrios FilippouDepartment of Anatomy and Surgery, School of Medicine, National and Kapodistrian University of Athens, Athens, GRC.
Dimosthenis ChrysikosDepartment of Anatomy, School of Medicine, National and Kapodistrian University of Athens, Athens, GRC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing cutaneous sarcoma that presents diagnostic and therapeutic challenges. This case report refers to a 47-year-old female patient who presented to the dermatologist with a stable, asymptomatic, firm lesion located on the proximal lower extremity. Local surgical excision was performed, and the specimen was sent for biopsy, where histopathological analysis, along with immunohistochemistry, confirmed the diagnosis of DFSP. Fluorescence in situ hybridization (FISH) analysis was also conducted, serving a supportive role in the detection of the tumor by confirming the presence of a COL1A1-PDGFB (collagen type I alpha 1 chain-platelet-derived growth factor beta) fusion gene, which is found in the majority of affected patients. As the initial excision left close margins, a second one was performed with subsequent skin grafting, and the final histopathology confirmed clear borders. The following clinical case highlights the necessity of prompt diagnosis in skin lesions that often mimic benign conditions but are, in fact, locally aggressive. It further underscores the paramount importance of adequate surgical excision with histologically healthy margins, as recurrence rates differ significantly based on the surgical technique; more specifically, after wide local excision (WLE), the possibility of relapse falls to 4%-20%, compared to cases with narrow or positive margins, which are associated with even higher rates. This emphasizes the need to secure clear margins after the final excision, along with a structured follow-up to minimize recurrence and improve patient outcomes.

Indexed as

cd34 positive tumorcol1a1-pdgfb fusion genedermatofibrosarcoma protuberansdfsprare skin cancerskin sarcomawide local excision

Identifiers

PMID41189839
PMCPMC12580859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.